We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
Read MoreHide Full Article
In the latest trading session, Tenet Healthcare (THC - Free Report) closed at $191.78, marking a -2.35% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.3%. Elsewhere, the Dow saw a downswing of 0.48%, while the tech-heavy Nasdaq appreciated by 0.03%.
Prior to today's trading, shares of the hospital operator had gained 15.2% outpaced the Medical sector's gain of 7.07% and the S&P 500's gain of 2.09%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. It is anticipated that the company will report an EPS of $3.35, marking a 14.33% rise compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $5.25 billion, reflecting a 2.42% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $15.54 per share and a revenue of $21.15 billion, signifying shifts of +30.81% and +2.36%, respectively, from the last year.
Investors should also note any recent changes to analyst estimates for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Tenet Healthcare is currently sporting a Zacks Rank of #1 (Strong Buy).
In the context of valuation, Tenet Healthcare is at present trading with a Forward P/E ratio of 12.64. This expresses a premium compared to the average Forward P/E of 10.77 of its industry.
It's also important to note that THC currently trades at a PEG ratio of 0.86. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 1.08 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 58, putting it in the top 24% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Tenet Healthcare (THC - Free Report) closed at $191.78, marking a -2.35% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.3%. Elsewhere, the Dow saw a downswing of 0.48%, while the tech-heavy Nasdaq appreciated by 0.03%.
Prior to today's trading, shares of the hospital operator had gained 15.2% outpaced the Medical sector's gain of 7.07% and the S&P 500's gain of 2.09%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. It is anticipated that the company will report an EPS of $3.35, marking a 14.33% rise compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $5.25 billion, reflecting a 2.42% rise from the equivalent quarter last year.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $15.54 per share and a revenue of $21.15 billion, signifying shifts of +30.81% and +2.36%, respectively, from the last year.
Investors should also note any recent changes to analyst estimates for Tenet Healthcare. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Tenet Healthcare is currently sporting a Zacks Rank of #1 (Strong Buy).
In the context of valuation, Tenet Healthcare is at present trading with a Forward P/E ratio of 12.64. This expresses a premium compared to the average Forward P/E of 10.77 of its industry.
It's also important to note that THC currently trades at a PEG ratio of 0.86. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Hospital industry had an average PEG ratio of 1.08 as trading concluded yesterday.
The Medical - Hospital industry is part of the Medical sector. This group has a Zacks Industry Rank of 58, putting it in the top 24% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.